HTML from...
URL: https://open.canada.ca/data/en/dataset/36133e8f-2032-4eb6-bb1a-e10bf46f714d
Canadians with rare diseases want access to drugs that could help manage and treat their conditions. Those drugs, however, can be extremely expensive. Advisory Council on the Implementation of National Pharmacare recommended creating a national strategy for providing fair, consistent and evidence-based access for patients to these specialized drugs. In response, the Government of Canada made a commitment to work with provinces, territories and other partners to create a national strategy for drugs for rare diseases.
There are no views created for this resource yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | January 16, 2026 |
| Metadata last updated | January 16, 2026 |
| Created | January 16, 2026 |
| Format | HTML |
| License | License not specified |
| Datastore active | False |
| Has views | False |
| Id | b2576446-79fb-4a69-88b5-96a584fc7039 |
| Package id | 1c56568c-2dfc-4d78-adb1-ff08da624ac1 |
| Position | 0 |
| State | active |